These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19423674)

  • 1. Impact of third-generation drugs on the activity of first-line chemotherapy in advanced non-small cell lung cancer: a meta-analytical approach.
    Grossi F; Aita M; Defferrari C; Rosetti F; Brianti A; Fasola G; Vinante O; Pronzato P; Pappagallo G
    Oncologist; 2009 May; 14(5):497-510. PubMed ID: 19423674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weekly paclitaxel in elderly patients (aged > or = 70 years) with advanced non-small-cell lung cancer: an alternative choice? Results of a phase II study.
    Rossi D; Dennetta D; Ugolini M; Alessandroni P; Catalano V; Fedeli SL; Giordani P; Casadei V; Baldelli AM; Graziano F; Catalano G
    Clin Lung Cancer; 2008 Sep; 9(5):280-4. PubMed ID: 18824450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy analysis of third-generation plus platinum doublets in the first-line chemotherapy of advanced non-small cell lung cancer].
    Zhao LD; Zhang XR; Li JL; Wang ZP; Wang Y; Hao XZ; Hu XS; Zhou SY; Sun Y; Shi YK
    Zhonghua Yi Xue Za Zhi; 2012 Jun; 92(22):1527-31. PubMed ID: 22944054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panel.
    Gridelli C; Aapro M; Ardizzoni A; Balducci L; De Marinis F; Kelly K; Le Chevalier T; Manegold C; Perrone F; Rosell R; Shepherd F; De Petris L; Di Maio M; Langer C
    J Clin Oncol; 2005 May; 23(13):3125-37. PubMed ID: 15860872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic strategy for treatment of metastatic non-small cell lung cancer.
    Berhoune M; Banu E; Scotte F; Prognon P; Oudard S; Bonan B
    Ann Pharmacother; 2008 Nov; 42(11):1640-52. PubMed ID: 18957625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chemotherapy for metastatic non-small cell lung cancer].
    Pérol M; Moro-Sibilot D
    Rev Mal Respir; 2005 Dec; 22(6 Pt 2):8S131-6. PubMed ID: 16340849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of single-agent chemotherapy compared with combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer.
    Di Maio M; Chiodini P; Georgoulias V; Hatzidaki D; Takeda K; Wachters FM; Gebbia V; Smit EF; Morabito A; Gallo C; Perrone F; Gridelli C
    J Clin Oncol; 2009 Apr; 27(11):1836-43. PubMed ID: 19273711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing chemotherapy for advanced non-small cell lung cancer: focus on docetaxel.
    Belani CP
    Lung Cancer; 2005 Dec; 50S2():S3-S8. PubMed ID: 16551520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Stage IV NSCLC. Place of chemotherapy].
    Meert AP
    Rev Mal Respir; 2008 Oct; 25(8 Pt 2):3S107-12. PubMed ID: 18971834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose intensity correlate with survival in elderly patients treated with chemotherapy for advanced non-small cell lung cancer.
    Luciani A; Bertuzzi C; Ascione G; Di Gennaro E; Bozzoni S; Zonato S; Ferrari D; Foa P
    Lung Cancer; 2009 Oct; 66(1):94-6. PubMed ID: 19171407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do the time to chemotherapy response and the dose intensity have an impact on patient outcome in advanced non-small cell lung cancer?
    Radosavljevic D; Golubicic I; Gavrilovic D; Kezic I; Jelic S
    J BUON; 2009; 14(2):203-9. PubMed ID: 19650167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends and predictors of first-line chemotherapy use among elderly patients with advanced non-small cell lung cancer in the United States.
    Lang K; Marciniak MD; Faries D; Stokes M; Buesching D; Earle C; Treat J; Morissette N; Thompson D
    Lung Cancer; 2009 Feb; 63(2):264-70. PubMed ID: 18649969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Stage IV non-small cell lung cancer. Duration of chemotherapy for locally advanced non small cell lung cancers].
    Vergnenègre A
    Rev Mal Respir; 2006 Nov; 23(5 Pt 3):16S72-16S77. PubMed ID: 17268340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnitude of benefit of adjuvant chemotherapy for non-small cell lung cancer: meta-analysis of randomized clinical trials.
    Bria E; Gralla RJ; Raftopoulos H; Cuppone F; Milella M; Sperduti I; Carlini P; Terzoli E; Cognetti F; Giannarelli D
    Lung Cancer; 2009 Jan; 63(1):50-7. PubMed ID: 18565615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of amifostine on response rates in locally advanced non-small-cell lung cancer patients treated on randomized controlled trials: a meta-analysis.
    Mell LK; Malik R; Komaki R; Movsas B; Swann RS; Langer C; Antonadou D; Koukourakis M; Mundt AJ
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):111-8. PubMed ID: 17289291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine triphosphate-based chemotherapy response assay (ATP-CRA)-guided versus empirical chemotherapy in unresectable non-small cell lung cancer.
    Moon YW; Sohn JH; Kim YT; Chang H; Jeong JH; Lee YJ; Chang J; Kim SK; Jung M; Hong S; Choi SH; Kim JH
    Anticancer Res; 2009 Oct; 29(10):4243-9. PubMed ID: 19846981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A Meta-Analysis of Platinum Plus Gemcitabine or Vinorelbine for Advanced Non-small Cell Lung Cancer.].
    Gao G; Zhou X; Huang R; Jiang J; Chu Z; Zhan Q; Liang X
    Zhongguo Fei Ai Za Zhi; 2009 Jan; 12(1):38-43. PubMed ID: 20712955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of third-generation chemotherapy on the survival of patients with advanced non-small cell lung cancer in Norway: a national study.
    von Plessen C; Strand TE; Wentzel-Larsen T; Omenaas E; Wilking N; Sundstrøm S; Sörenson S
    Thorax; 2008 Oct; 63(10):866-71. PubMed ID: 18390631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [First-line treatment of metastatic non-small cell lung cancers].
    Pérol M
    Rev Pneumol Clin; 2004 Nov; 60(5 Pt 2):3S51-6. PubMed ID: 15536354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patterns-of-failure analysis.
    Rusthoven KE; Hammerman SF; Kavanagh BD; Birtwhistle MJ; Stares M; Camidge DR
    Acta Oncol; 2009; 48(4):578-83. PubMed ID: 19373699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.